APA (7th ed.) Citation

Schneider, M., Neoptolemos, J. P., & Büchler, M. W. (2020). Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence. Surgery, 168(6), . https://doi.org/10.1016/j.surg.2020.07.033

Chicago Style (17th ed.) Citation

Schneider, Martin, John P. Neoptolemos, and Markus W. Büchler. "Commentary: Neoadjuvant Treatment of Resectable Pancreatic Cancer: Lack of Level III Evidence." Surgery 168, no. 6 (2020). https://doi.org/10.1016/j.surg.2020.07.033.

MLA (9th ed.) Citation

Schneider, Martin, et al. "Commentary: Neoadjuvant Treatment of Resectable Pancreatic Cancer: Lack of Level III Evidence." Surgery, vol. 168, no. 6, 2020, https://doi.org/10.1016/j.surg.2020.07.033.